Multidrug-Resistant

Treatment Outcomes in Multidrug-Resistant Tuberculosis

More on Treatment Outcomes in Multidrug-Resistant Tuberculosis

Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey

Data on availability and cost of anti-tuberculosis (TB) drugs in relation to affordability at national level are scarce. We performed a cross-sectional study on availability and cost of anti-TB drugs at major TB-reference centres in 37 European …

Evaluation of the Genotype® MTBDRplus assay as a tool for drug resistance surveys

SETTING A national tuberculosis (TB) drug resistance survey in Tanzania. OBJECTIVE To compare the performance of the Genotype® MTBDRplus line-probe assay (LPA) on smear-positive sputum specimens with conventional culture and isoniazid (INH) plus …

National anti-tuberculosis drug resistance study in Tanzania

OBJECTIVE: To assess the prevalence of anti-tuberculosis drug resistance in a national representative sample of tuberculosis (TB) patients in Tanzania according to recommended methodology. DESIGN: Cluster survey, with 40 clusters sampled proportional …

Annual meeting of the Tuberculosis Surveillance and Research Unit, 2008

The Tuberculosis Surveillance and Research Unit (TSRU) held its last annual meeting in Helsinki, Finland, from 1 to 4 April 2008. Several topics of current interest for tuberculosis (TB) research and new research projects were presented and discussed …

Implementation of a national anti-tuberculosis drug resistance survey in Tanzania

ABSTRACT: BACKGROUND: A drug resistance survey is an essential public health management tool for evaluating and improving the performance of National Tuberculosis control programmes. The current manuscript describes the implementation of the first …